Brain inflammation in the race against dementia
Brain inflammation in the race against dementia
Most dementias are degenerative, comprising wear and tear of brain cells, and a build-up of harmful junk proteins and chronic brain inflammation. Higher brain inflammation is linked to more severe symptoms and faster decline over time. Whilst anti-inflammatory or immunity-based treatments might slow or prevent decline, better tests to measure inflammation are needed to identify who may benefit most from these treatments, determine when to treat, and to know which part of the immune system to target. Discover how Dr Malpetti’s team use specialist brain scans and novel blood tests to measure inflammation in volunteers with different dementia types, to accelerate the development of new treatments.
Speaker
Dr Maura Malpetti (Sidney Sussex 2017)

Dr Maura Malpetti is a Race Against Dementia Alzheimer’s Research UK Fellow and a Senior Research Associate in the Department of Clinical Neurosciences at the University of Cambridge. She originally trained in Italy and after obtaining her PhD in Clinical Neurosciences in Cambridge, further trained as a visiting researcher at the University of California San Francisco, and the Ludwig Maximilian University of Munich. Her research focuses on the application of brain scans and blood tests to measure early brain changes, like inflammation and the accumulation of junk proteins, that can forecast clinical outcomes in people with several types of dementia. Her work aims to identify clinically relevant biomarkers and targets for early detection, more accurate prognosis and effective treatments in people living with these conditions.
Booking information
In-person lectures at the Sidgwick Site as part of Alumni Festival cost £15 per person.
Booking for this event is now closed.